Physician profile
Pearl Thai
NPI 1295288272
$1,638.53
in general payments reported to CMS, 2019-2025
14 companies · $548 in 2025
The $548 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $31.69 · 2021: $114 · 2022: $199 · 2023: $348 · 2024: $298 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.68 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $340.63 | 2023-2025 | Biotrue, Infuse, Miebo |
| Alcon Vision LLC | $311.09 | 2023-2025 | Precision7, Tryptyr, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $163.07 | 2019-2021 | |
| Abbvie INC. | $157.15 | 2022-2025 | Durysta |
| Glaukos Corporation | $151.61 | 2022-2025 | Istent Infinite, Idosetr |
| Oyster Point Pharma, INC. | $101.64 | 2022-2025 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $99.37 | 2023-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $85.12 | 2020-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $64.97 | 2020-2024 | Cequa |
| Eyevance Pharmaceuticals LLC | $51.34 | 2021 | |
| Rxsight INC | $41.47 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Harrow Eye, LLC | $26.88 | 2024 | Vevye, Natacyn |
| Allergan, INC. | $23.15 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $21.04 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pearl Thai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.